A 62-year-old man with type 2 diabetes and CKD stage G3a A2 (eGFR 55 mL/min/1.73 m², ACR 12 mg/mmol) has well-controlled blood pressure on amlodipine alone. According to Australian CKD guidelines, which change is most appropriate to reduce his risk of kidney disease progression and cardiovascular events?